Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 4Small Cell Lung Carcinoma 2Multiple Myeloma 2Hematologic Neoplasms 2Neutropenia 1Lymphoma, Non-Hodgkin 1Advanced Pancreatic Cancer 1

Interventions

Cyclophosphamide 21Cyclosporine 14fludarabine phosphate 13Whole-Body Irradiation 13Peripheral Blood Stem Cell Transplantation 13Filgrastim 10Rituximab 9Mycophenolic Acid 9Antilymphocyte Serum 9Radiotherapy 7Methotrexate 7Busulfan 7Melphalan 6Psychiatric Rehabilitation 5Etoposide 5Dexamethasone 5Cytarabine 5Aprepitant 5fludarabine 4Vincristine 4Ondansetron 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4Doxorubicin 4Cord Blood Stem Cell Transplantation 4plerixafor 3Zidovudine 3Therapeutics 3Stem Cell Transplantation 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Non-Hodgkin × pegylated granulocyte colony-stimulating factor × Clear all
NCT04497688 2020-08-04

Evaluate the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia After Chemotherapy in Patients With Non-Hodgkin's Lymphoma

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.

Phase NA Unknown
104 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡